Vantage Point Financial LLC Oncolytics Biotech Inc Transaction History
Vantage Point Financial LLC
- $258 Billion
- Q3 2025
A detailed history of Vantage Point Financial LLC transactions in Oncolytics Biotech Inc stock. As of the latest transaction made, Vantage Point Financial LLC holds 29,744 shares of ONCY stock, worth $31,231. This represents 0.02% of its overall portfolio holdings.
Number of Shares
29,744
Previous 29,744
-0.0%
Holding current value
$31,231
Previous $23 Million
81.12%
% of portfolio
0.02%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding ONCY
# of Institutions
58Shares Held
2.82MCall Options Held
0Put Options Held
0-
Morgan Stanley New York, NY383KShares$402,5130.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il382KShares$401,1530.0% of portfolio
-
Marshall Wace, LLP London, X0324KShares$340,1810.0% of portfolio
-
Seeds Investor LLC New York, NY258KShares$271,2210.08% of portfolio
-
Goldman Sachs Group Inc New York, NY209KShares$219,1320.0% of portfolio
About ONCOLYTICS BIOTECH INC
- Ticker ONCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 57,867,400
- Market Cap $60.8M
- Description
- Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...